DK2240462T3 - 3,5-dihydroxycyclopentanderivater til anvendelse i behandling af glaukom eller okulær hypertension og til stimulering af hårvækst - Google Patents

3,5-dihydroxycyclopentanderivater til anvendelse i behandling af glaukom eller okulær hypertension og til stimulering af hårvækst

Info

Publication number
DK2240462T3
DK2240462T3 DK09702525.8T DK09702525T DK2240462T3 DK 2240462 T3 DK2240462 T3 DK 2240462T3 DK 09702525 T DK09702525 T DK 09702525T DK 2240462 T3 DK2240462 T3 DK 2240462T3
Authority
DK
Denmark
Prior art keywords
glaucome
dihydroxycyclopentane
derivatives
treatment
hair growth
Prior art date
Application number
DK09702525.8T
Other languages
Danish (da)
English (en)
Inventor
Brent A Johnson
David W Old
Yariv Donde
Robert M Burk
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK2240462T3 publication Critical patent/DK2240462T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK09702525.8T 2008-01-18 2009-01-14 3,5-dihydroxycyclopentanderivater til anvendelse i behandling af glaukom eller okulær hypertension og til stimulering af hårvækst DK2240462T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2228208P 2008-01-18 2008-01-18
US12/352,995 US7964595B2 (en) 2008-01-18 2009-01-13 Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension
PCT/US2009/030895 WO2009091765A1 (en) 2008-01-18 2009-01-14 Therapeutic compounds

Publications (1)

Publication Number Publication Date
DK2240462T3 true DK2240462T3 (da) 2013-10-28

Family

ID=40876973

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09702525.8T DK2240462T3 (da) 2008-01-18 2009-01-14 3,5-dihydroxycyclopentanderivater til anvendelse i behandling af glaukom eller okulær hypertension og til stimulering af hårvækst

Country Status (9)

Country Link
US (1) US7964595B2 (https=)
EP (1) EP2240462B1 (https=)
JP (1) JP5393700B2 (https=)
AU (1) AU2009205478B2 (https=)
BR (1) BRPI0906879A2 (https=)
CA (1) CA2712192C (https=)
DK (1) DK2240462T3 (https=)
ES (1) ES2434963T3 (https=)
WO (1) WO2009091765A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG193840A1 (en) * 2008-09-04 2013-10-30 Santen Pharmaceutical Co Ltd HAIR GROWTH PROMOTING AGENT CONTAINING 15,15-DIFLUOROPROSTAGLANDIN F2a DERIVATIVE AS ACTIVE INGREDIENT
WO2013180229A1 (ja) * 2012-05-30 2013-12-05 旭硝子株式会社 育毛用組成物
US9540357B1 (en) 2014-07-31 2017-01-10 Allergan, Inc. 15-aryl prostaglandins as EP4 agonists, and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543353A (en) * 1981-11-27 1985-09-24 Farmitalia Carlo Erba S.P.A. Ester and amide derivatives of 13,14-didehydro prostaglandins
JPH0692305B2 (ja) * 1987-05-15 1994-11-16 株式会社上野製薬応用研究所 体温上昇剤
US5688819A (en) 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
WO2000051977A1 (en) * 1999-03-05 2000-09-08 The Procter & Gamble Company Aldehyde intermediates for the preparation of prostaglandin derivatives
JP4834224B2 (ja) * 1999-03-05 2011-12-14 デューク ユニバーシティ Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
US7166730B2 (en) 2000-01-27 2007-01-23 Fine Tech Laboratories, Ltd Process for the preparation of prostaglandin derivatives
IL143477A (en) 2001-05-31 2009-07-20 Finetech Pharmaceutical Ltd Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
US7101904B2 (en) * 2004-08-10 2006-09-05 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7427685B2 (en) * 2005-12-06 2008-09-23 Allergan, Inc. Therapeutic substituted cyclopentanes
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use

Also Published As

Publication number Publication date
WO2009091765A1 (en) 2009-07-23
JP5393700B2 (ja) 2014-01-22
AU2009205478B2 (en) 2014-01-16
JP2011522775A (ja) 2011-08-04
CA2712192A1 (en) 2009-07-23
CA2712192C (en) 2016-06-14
EP2240462B1 (en) 2013-08-21
BRPI0906879A2 (pt) 2015-07-07
EP2240462A1 (en) 2010-10-20
US20090186885A1 (en) 2009-07-23
US7964595B2 (en) 2011-06-21
ES2434963T3 (es) 2013-12-18
AU2009205478A1 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
DK3205334T3 (da) Fremgangsmåde og sammensætning til behandling okulær hypertension og glaukom
DK1799235T3 (da) Sammensætninger af fosterhudcelleprotein til behandling af hudtilstande, -lidelser eller -sygdomme og fremgangsmåder til fremstilling og anvendelse deraf
DK1917246T3 (da) Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme
CY2018026I1 (el) Χρηση στρωματικων βλαστοκυτταρων λαμβανομενων απο λιπωδη ιστο στην θεραπεια συριγγιου
BRPI0912292A2 (pt) composições e métodos para o uso de células no tratamento do tecido cardíaco.
DK1765322T3 (da) Retinal-derivater og fremgangsmåder til anvendelse deraf i behandlingen af synsforstyrrelser
HUE040019T2 (hu) Hajnövekedést stimuláló készítmények és módszerek
DK2114419T3 (da) Natriummetaarsenit til anvendelse i behandling af smerte og inflammation
DK2297106T3 (da) Phenoxypyridinylamidderivater og deres anvendelse til behandling af pde4-medierede sygdomstilstande
DK2796469T3 (da) Hidtil ukendte sammensætninger og fremgangsmåder til behandling af IgE-medierede forstyrrelser
BRPI0816214A2 (pt) Uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas
BRPI0915986A2 (pt) composição, métodos para tratar uma condição, para retardar o início de uma condição, para reduzir o risco em um indivíduo de adquirir uma condição e para alterar a expressão de um ou mais genes em um indivíduo
BRPI0810270A2 (pt) "implante de válvula cardíaca e método de implante"
SI2894165T1 (sl) Postopki in sestavki za zdravljenje motenj povezanih s komplementom
LT2254869T (lt) Nauji 1-benzil-3-hidroksimetilindazolo dariniai ir jų panaudojimas gydyme ligų, susijusių su cx3cr1 ir p40 raiška
ZA201002550B (en) Hair care compositions and methods of treating hair
PL2257155T3 (pl) Krioprezerwacja komórek i tkanek biologicznych
EP2134854A4 (en) METHOD OF TREATMENT USING EGFR ANTIBODIES AND CRS INHIBITORS, AND RELATED FORMULATIONS
DK2158201T3 (da) Derivater af 7-alkynyl-1,8-naphthyridon, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapi
IL219318A (en) 3,5-dimethoxy-4'-hydroxystilbene (pter) for use in the treatment of skin diseases , damages or injuries and process for preparing the same
IL202293A0 (en) 1,(,3)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation
DK2262778T5 (da) 1-benzyl-3-hydroxymethylindazolderivativer og brug deraf i behandling af sygdomme baseret på ekspression af mcp-1, cx3cr1 og p40
BRPI0822843A2 (pt) "dispositivo portátil para tratamento de cabelo para estimulação de crescimento do cabelo no couro cabeludo"
IL209336B (en) Compositions for treating hyperproliferative diseases and uses thereof
DK2407474T3 (da) Triacetyl-3-hydroxyfenyladenosin og dets anvendelse til regulering af blodfedt